PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
+0.8%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$283M
AUM Growth
+$283M
(+12%)
Cap. Flow
+$39.9M
Cap. Flow
% of AUM
14.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Rallybio
RLYB
|
$39.9M |
| 2 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$16 |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $104M | 36.87% | 852,708 | – | – |
|
|
2
Rallybio
RLYB
$22.4M
| $39.9M | 14.11% | +2,271,311 | New | +$39.9M |
|
3
Vaxcyte
PCVX
$4B
| $35.7M | 12.6% | 1,405,421 | – | – |
|
4
Bolt Biotherapeutics
BOLT
$9.85M
| $23.9M | 8.46% | 1,891,467 | – | – |
|
|
AKUS
5
DELISTED
Akouos, Inc. Common Stock
AKUS
| $20.8M | 7.36% | 1,794,088 | – | – |
|
|
INZY
6
DELISTED
Inozyme Pharma
INZY
| $18.4M | 6.52% | 1,591,154 | – | – |
|
7
Aligos Therapeutics
ALGS
$73.3M
| $13.6M | 4.8% | 876,548 | – | – |
|
8
Arcutis Biotherapeutics
ARQT
$1.86B
| $13.6M | 4.8% | 569,041 | – | – |
|
|
FUSN
9
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $12.7M | 4.47% | 1,598,379 +2 | +0% | +$16 |
|